Nucleic acids encoding antiviral proteins and peptides, vectors

Details Nucleic acids encoding antiviral proteins and peptides, vectors Nucleic acids encoding antiviral proteins and peptides, vectors

1996-04-26

1998-10-13

Kemmerer, Elizabeth C.

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

536 231, 536 237, 4353201, 4352523, 435325, 4351723, C12N 1511, C12N 111, C12N 510, C12N 1563

Patent

active

058210814

ABSTRACT:
The present invention provides antiviral proteins (collectively referred to as cyanovirins), conjugates thereof, DNA sequences encoding such agents, host cells containing such DNA sequences, antibodies directed to such agents, compositions comprising such agents, and methods of obtaining and using such agents.

REFERENCES:
Lewin, Science 237:1570, 1987.
Reeck et al., Cell 50:667, 1987.
Agnew et al., "The Effect of Treatment Regimens for Vaginitis and Cervicitis on Vaginal Colonization by Lactobacilli," Sexually Transmitted Diseases, 22(5), 269-273 (1995).
Andreau et al., "Hemagglutination, Adherence, and Surface Properties of Vaginal Lactobacillus Species," J. Infect. Diseases, 171, 1237-1243 (1995).
Bruce et al., "Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections," Can. J. Microbiol., 34, 339-343 (1988).
Buckheit et al., "Biological and biochemical anti-HIV activity of the benzothiadiazine class nonnucleoside reverse transcriptase inhibitors," Antiviral Research, 25, 43-56 (1994).
Buckheit et al., "Potent and Specific Inhibition of HIV Envelope-Mediated Cell Fusion and Virus Binding by G Quartet-Forming Ogionucleotide (ISIS 5320)," Aids Research and Human Retroviruses, 10(11), 1497-1506 (1994).
Elmer et al., "Biotherapeutic Agents," JAMA, 275(11), 870-876(1996).
Goudswaard et al., "Protein A Reactivity of Various Mammalian Immunoglobulins," Scand. J. Immunol., 8, 21-28 (1978).
Hillier et al., "The Normal Vaginal Flora, H.sub.2 O.sub.2 -Producing Lactobacilli, and Bacterial Vaginosis in Pregnant Women," Clinical Infectious Diseases, 16, S273-S281 (1993).
Hillier, "A Healthy Vaginal Ecosystem is Important for Prevention of HIV Transmission: Why and How?," presented at Conference on Advances in AIDS Vaccine Development, Bethesda, Maryland (Feb. 11-15, 1996).
Hols et al., "Use of Homologous Expression-Secretion Signals and Vector-Free Stable Chromosomal Integration in Engineering of Lactobacillus Plantarum for .alpha.-Amylase and Levanase Expression," Applied and Enviromental Microbiology, 60(5), 1401-1413 (1994).
Krietman et al., "Recombinant Immunotoxins Containing Anti-Tac(FV) and Derivatives of Pseudomonas Exotoxin Produce Compete Regression in Mice of an Interleukin-2 Receptor-Expressing Human Carcinoma," Blood, 83(2), 426-434 (1994).
Laemmli, "Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4," Nature, 227, 680-685 (1970).
Lange et al., "Boost for vaginal microbicides against HIV," The Lancet, 341, 1356 (1993).
McGroarty, "Probiotic use of lactobacilli in the human female urogenital tract," FEMS Immunology and Medical Microbiology, 6, 251-264 (1993.
Painter, "Developing women-friendly AIDS protection will take time," USA Today(Feb. 13, 1996).
Perelson et al., "HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time," Science, 271, 1582-1586 (1996).
Redondo-Lopez et al., "Emerging Role of Lactobacilli in the Control and Maintenance of the Vaginal Bacterial Microflora," Reviews of Infectious Diseases, 12(5), 856-872 (1990).
Reid et al., "Is There a Role for Lactobacilli in Prevention of Urogenital and Intestinal Infections?," Clinical Microbiology Reviews, 3(4), 335-344 (1990).
Walker, "NIAID Expands Research on Topical Microbicides to Prevent STDs in Women," NIAID News (press release), (Apr. 27, 1995).
Abuchowski et al., "Soluble Polymer-Enzyme Adducts," in Enzymes as Drugs, Holcenberg et al., eds., John Wiley: New York, 1981, pp. 367-383.
Abuchowski et al., Alteration of Immunological Properties of Bovine Serum Albumin by Covalent Attachment of Polyethylene Glycol, Journal of Biological Chemistry, 252(11), 3578-3581 (1977).
Aullo et al., "A Recombinant Diphtheria Toxin Related Human CD4 Fusion Protein Specifically Kills HIV Infected Cells Which Express gp120 But Selects Fusion Toxin Resistant Cells Which Carry HIV," EMBO Journal, 11(2), 575-583 (1992).
Balter, "UN Readies New Global AIDS Plan," Science, 266, 1312-1313.
Banga et al., "Systemic Delivery of Therapeutic Peptides and Proteins," International Journal of Pharmaceutics, 48, 15-50 (1988).
Barry, "The Transdermal Route for the Delivery of Peptides and Proteins," in Delivery Systems for Peptide Drugs, Davis et al., eds., Plenum Press: New York, 1986, pp. 265-275.
Berzofsky, "Approaches and Issues in the Development of Vaccines Against HIV," Journal of Acquired Immune Deficiency Syndromes, 4, 451-459 (1991).
Bird, "The Use of Spermicide Containing Nonoxynol-9 in the Prevention of HIV Infection," AIDS, 5(7), 791-796 (1991).
Bourinbaiar et al., "Anti-HIV Effect of Gramicidin In Vitro: Potential for Spermicide Use," Life Sciences, 54(1), 5-9 (1994).
Bourinbaiar et al., "Comparative In Vitro Study of Contraceptive Agents with Anti-HIV Activity: Gramicidin, Nonoxynol-9, and Gossypol," Contraception, 49, 131-137 (1994).
Boyd, "Strategies for the Identification of New Agents for the Treatment of AIDS: A National Program to Facilitate the Discovery and Preclinical Development of New Drug Candidates for Clinical Evaluation," AIDS Etiology, Diagnosis, Treatment, and Prevention, Second Edition, DeVita et al., eds., J.B. Lippincott Company, 1988, pp. 305-317.
Boyd et al., "Anti-HIV Michellamines from Ancistrocladus korupensis," Journal of Medicinal Chemistry, 37(12), 1740-1745 (1994).
Capon et al., "Designing CD4 Immunoadhesins for AIDS Therapy," Nature, 337, 525-531 (1989).
Capon et al., "The CD4-gp120 Interaction and AIDS Pathogenesis," Annu. Rev. Immunol., 9, 649-678 (1991).
Carone et al., "Renal Tubular Processing of Small Peptide Hormones," The Journal of Laboratory and Clinical Medicine, 100(1), 1-14 (1982).
Carter et al., "Structure of Majusculamide C, a Cyclic Depsipeptide from Lyngbya majuscula," J. Org. Chem., 49, 236-241 (1984).
Chaudhary et al., "Selective Killing of HIV-Infected Cells by Recombinant Human CD4-Pseudomonas Exotoxin Hybrid Protein," Nature, 335, 369-372 (1988).
Chaudhary et al., "CD4-PE40--A Chimeric Toxin Active Against Human Immunodeficiency Virus (HIV)-Infected Cells," The Human Retroviruses, pp. 379-387.
Coffin, John M., "HIV Population Dynamics In Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy," Science, 267, 483-489 (1995).
Cohen, "High Turnover of HIV in Blood Revealed by New Studies," Science, 267, 179 (1995).
Coll et al., "The Application of Vacuum Liquid Chromatograph to the Separation of Terpene Mixtures," Journal of Natural Products, 49(5), 934-936 (1986).
Davey et al., "Use of Recombinant Soluble CD4 Pseudomonas Exotoxin, a Novel Immunotoxin, for Treatment of Persons Infected with Human Immunodeficiency Virus," Journal of Infectious Diseases, 170, 1180-1188 (1994).
Davis, "Delivery Systems for Bipharmaceuticals," J. Pharm. Pharmacol., 44(Suppl. 1), 186-190 (1992).
De Clercq, "Antiviral Agents: Characteristic Activity Spectrum Depending on the Molecular Target with which They Interact," Advances In Virus Research, 42, 1-55 (1993).
De Clerq, "Basic Approaches to Anti-Retroviral Treatment," Journal of Acquired Immune Deficiency Syndromes, 4(3), 207-218 (1991).
Deasy et al., in Microencapsulation and Related Processes, Swarbrick J., ed., Marcel Dekker, Inc.: New York, 1984, pp. 1-60.
Emtage, "Biotechnology and Protein Production," in Delivery Systems for Peptide Drugs, Davis et al., eds., Plenum Press: New York, 1986, pp. 23-33.
Eppstein et al., "Alternative Delivery Systems for Peptides and Proteins as Drugs," CRC Critical Reviews in Therapeutic Drug Carrier Systems, 5(2), 99-139 (1988).
Faulkner, "Marine Natural Products," Natural Product Reports, pp. 355-394 (1994).
Frankmolle et al., "Antifungal Cyclic Peptides from the Terrestrial Blue-Green Alga Anabaena laxa," The Journal of Antibiotics, 45(9), 1451-1457 (1992).
Freed et al., "The Role of the HIV Envelope Glycoproteins in Cell Fusion and the Pathogenesis of AIDS," Bull. Inst. Pasteur, 88, 73-110 (1990).
Glombitza et al., in Algal and Cyanobacterial Biotechnology, Cresswell, R.C., et al., eds., 1989, pp. 211-218.
Gulakowski et al., "A Semiautomated Multiparameter Approach for Anti-HIV Drug Screening,

Affiliated with

Also associated with

Rating

Nucleic acids encoding antiviral proteins and peptides, vectors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acids encoding antiviral proteins and peptides, vectors , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids encoding antiviral proteins and peptides, vectors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-312384